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Abstract
Acinetobacter baumannii is a pathogen that is becoming increasingly important and causes serious hospital-
acquired infections. We sequenced the genome of A. baumannii NCTC 13423, a multidrug-resistant strain belonging
to the international clone II group, isolated from a human infection in the United Kingdom in 2003. The
3,937,944 bp draft genome has a GC-content of 39.0 % and a total of 3672 predicted protein-coding sequences.
The availability of genome sequences of multidrug-resistant A. baumannii isolates will fuel comparative genomic
studies to help understand the worrying spread of multidrug resistance in this pathogen.
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Introduction
Acinetobacter baumannii recently emerged as an in-
creasingly important pathogen causing healthcare-
associated bloodstream, urinary tract, pulmonary, and
device-related infections [1]. A. baumannii strains are
often resistant against multiple antibiotics, owing to
their high intrinsic resistance and a variety of acquired
resistance mechanisms [2]. Carbapenem is usually an ef-
fective treatment choice, but carbapenem-resistant
strains are globally on the rise, and alternative treatment
options are limited [3].
Here, we present the draft genome sequence of A. bau-
mannii NCTC 13423, a strain belonging to international
clone lineage II isolated from a patient in a UK hospital in
December 2003 [4]. NCTC 13423 shows resistance to
ampicillin, amoxicillin-clavulanic acid, aztreonam, cefepime,
cefotaxime, ceftazidime, cefoxitin, piperacillin, piperacillin-
tazobactam, ciprofloxacin, gentamicin, and sulbactam [4].
Although originally reported as carbapenem-sensitive, a
later report classified it to be also carbapenem-resistant [5].
Additionally, this strain is highly virulent and a strong
biofilm producer [6].
Organism information
Classification and features
Bacteria in the genus Acinetobacter are Gram-negative,
strictly aerobic, nonfermenting, nonmotile, catalase-
positive, oxidase-negative coccobacilli [7] (Table 1). The
genus Acinetobacter has gone through many taxonomic
changes over the years, and the species A. baumannii
has only been officially recognized since 1986 [8, 9]. A.
baumannii belongs to the family Moraxellaceae, order
Pseudomonadales, class Gammaproteobacteria, and
phylum Proteobacteria. Acinetobacter species are ubiqui-
tous organisms, widely distributed in nature, and can be
recovered from virtually any soil or water sample. How-
ever, A. baumannii seems to be an exception to this rule,
as it currently has no known habitats except the hospital
[10]. Microscopically, they are often observed as pairs of
cells (Fig. 1). A. baumannii can withstand prolonged
desiccation, allowing it to survive on dry surfaces and
probably contributing to its persistent residence in hos-
pital settings [11]. A phylogenetic tree based on 16S
rDNA sequences showed strong clustering with other A.
baumannii strains (Fig. 2).
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Genome sequencing information
Genome project history
The strain NCTC 13423 was isolated in 2003 in the
United Kingdom from a repatriated casualty of the Iraq
conflict [4], and was selected for sequencing because of
its multidrug-resistant and virulence characteristics. Se-
quencing was carried out at the EMBL GeneCore facility
(Heidelberg, Germany). Sequences were assembled using
CLC Genomics Workbench (version 7.5.1) and anno-
tated using NCBI’s Prokaryotic Genome Annotation
Pipeline (PGAP). This draft whole-genome sequence has
been deposited at DDBJ/ENA/GenBank under the acces-
sion LOHD00000000. The project information, and its
association with MIGS version 2.0 [12], is summarised
in Table 2.
Growth conditions and genomic DNA preparation
Cultures for DNA isolation were inoculated from a sin-
gle colony on LB agar in 5 ml lysogeny broth and grown
overnight at 37 °C with orbital shaking (200 rpm). DNA
was isolated using the DNeasy Blood&Tissue Kit
(Qiagen) following the manufacturer’s instructions and
pre-treatment protocol for Gram-negative bacteria.
DNA concentration and purity were assessed using the
Nanodrop ND-1000 spectrophotometer and Qubit
fluorometer (ThermoFisher Scientific).
Genome sequencing and assembly
Sequencing was performed using the Nextera DNA
Library Preparation Kit with the Illumina HiSeq
2000 platform (100 bp, paired-end) at the EMBL
GeneCore facility (Heidelberg, Germany). The read
library contained a total of 8,765,016 sequences in
pairs. Sequence data was analysed using Qiagen’s
CLC Genomics Workbench (version 7.5.1). First,
reads were trimmed for quality (score limit 0.05) and
ambiguous nucleotides (maximum 2 ambiguities).
Next, de novo assembly was performed (mismatch
cost: 2, deletion cost: 3, insertion cost: 3, length
fraction: 0.5, similarity fraction: 0.8), yielding 196
contigs (minimum length 200 bp) with an average
coverage of 203x. Contigs averaged 20,092 bp in
length (N50 of 111,328 bp). The total length of the
Fig. 1 Phase-contrast micrograph of A. baumannii NCTC 13423
Table 1 Classification and general features of Acinetobacter
baumannii strain NCTC 13423 according to the MIGS
recommendations [12]
MIGS ID Property Term Evidence
codea
Classification Domain Bacteria TAS [29]
Phylum Proteobacteria TAS [30]
Class Gammaproteobacteria TAS [31, 32]
Order Pseudomonadales TAS [33, 34]
Family Moraxellaceae TAS [35]
Genus Acinetobacter TAS [34, 36]
Species Acinetobacter baumannii TAS [8]
Strain NCTC 13423 NAS
Gram stain Negative TAS [8]
Cell shape Coccobacillus TAS [8]
Motility Non-motile TAS [37]
Sporulation Non-sporulating TAS [8]
Temperature
range
Mesophilic TAS [38]
Optimum
temperature
37 °C TAS [38]
pH range;
Optimum
Unknown NAS
Carbon
source
Chemoorganoheterotrophic;
citrate, lactate, ethanol, glutarate,
malate, aspartate, tyrosine, 2,3-
butanediol, 4-aminobutyrate
TAS [8]
MIGS-6 Habitat Hospital NAS
MIGS-6.3 Salinity Unknown NAS
MIGS-22 Oxygen
requirement
Strictly aerobic TAS [8]
MIGS-15 Biotic
relationship
Free-living TAS [8]
MIGS-14 Pathogenicity Pathogenic TAS [4]
MIGS-4 Geographic
location
United Kingdom TAS [4]
MIGS-5 Sample
collection
12/2003 TAS [4]
MIGS-4.1 Latitude Unknown NAS
MIGS-4.2 Longitude Unknown NAS
MIGS-4.4 Altitude Unknown NAS
aEvidence codes, IDA inferred from direct assay, TAS traceable author
statement (i.e., a direct report exists in the literature), NAS non-traceable
author statement (i.e., not directly observed for the living, isolated sample, but
based on a generally accepted property for the species, or anecdotal
evidence). These evidence codes are from the Gene Ontology project [39]
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draft genome is 3,937,944 bp with a GC-content of
39.0 %.
Genome annotation
All contigs were annotated using NCBI’s Prokaryotic Gen-
ome Annotation Pipeline (PGAP). The Batch Web CD-
Search Tool from NCBI [13] was used to identify Pfam
domains [14] in the predicted protein sequences.
Classification of predicted proteins in Clusters of
Orthologous Groups (COG) functional categories [15]
was done with the WebMGA web server for metage-
nomic analysis [16]. Signal peptides, transmembrane
domains, and CRISPR repeats were predicted using
the SignalP 4.1 server [17], the TMHMM server [18],
and the CRISPRFinder tool [19], respectively. Only
confirmed and not questionable CRISPR hits were
taken into account.
Genome properties
Table 3 summarises the properties of the draft genome.
Reads were assembled into 196 contigs, totalling
3,937,944 bp with a 39.0 % GC-content. PGAP predicted
a total number of 3875 genes, including 3672 protein
coding genes (totalling 3,384,768 base pairs), 135 pseudo
genes, and 68 RNA genes (64 tRNA, 3 rRNA, and 1
ncRNA). 75.17 % of the protein-coding genes had a pu-
tative function assigned, the remainder was annotated as
a hypothetical protein. Additional characteristics of the
predicted genes are given in Table 3, and Table 4 shows
their distribution amongst the different functional COG
categories.
Insights from the genome sequence
Functional analysis of the genome sequence by RAST an-
notation [20] revealed A. baumannii ACICU as the closest
related sequenced neighbor. A. baumannii ACICU is an
epidemic, multidrug-resistant strain isolated from a hospital
Fig. 2 16S rRNA phylogenetic analysis showing the evolutionary relationship between A. baumannii NCTC 13423 and related type (T) and non-type A.
baumannii strains and Acinetobacter species. Moraxella catarrhalis was used as an outgroup. Genbank accession numbers of the aligned sequences are
indicated between brackets. Sequence alignment was performed using MUSCLE [27], and a neighbour-joining algorithm using the Kimura 2-
parameter distance model was used to construct a phylogenetic tree in MEGA (version 7) [28]. The rate variation among sites was modelled with a
gamma distribution (shape parameter = 1). The optimal tree with the sum of branch lengths = 0.1583 is shown, and bootstrap support values above
60 % (1000 replicates) are indicated next to the branches
Table 2 Project information
MIGS ID Property Term
MIGS-31 Finishing quality High-quality draft
MIGS-28 Libraries used One paired-end Illumina
library (Nextera)
MIGS-29 Sequencing platforms Illumina HiSeq 2000
MIGS-31.2 Fold coverage 203
MIGS-30 Assemblers CLC NGS Cell 7.5.1
MIGS-32 Gene calling method GeneMarkS+
Locus Tag AUC58
Genbank ID LOHD00000000
GenBank Date
of Release
2016/02/26
GOLD ID -
BIOPROJECT PRJNA305394
MIGS-13 Source Material
Identifier
NCTC 13423
Project relevance Medical
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outbreak in Rome [21]. The high genetic relatedness be-
tween A. baumannii ACICU and A. baumannii NCTC
13423 was confirmed by calculating their two-way average
amino acid identity (AAI), which was 99.30 % based on
3360 protein sequences [22]. Indicative for the
multidrug-resistant phenotype, annotations by RAST
included six different β-lactamase enzymes, among
which two AmpC-type β-lactamases (class C), a
metallo-β-lactamase (class B), two class A β-
lactamases (of which one TEM-type broad-spectrum
β-lactamase) and an oxa-51 like carbapenemase
(class D). Using TAfinder, a web-based tool to iden-
tify type II toxin-antitoxin (TA) loci in bacterial
genomes [23], we predicted the presence of 12 type
II TA modules in the A. baumannii NCTC 13423
draft genome. Considering only TAfinder hits with
normalized homology scores (H-value) > 0.5, five pu-
tative TA modules remain, three of which are also
present in the genome of A. baumannii ACICU.
Interestingly, A. baumannii has been reported to
form antibiotic-tolerant persister cells [24, 25], and
these TA modules might play a role in their forma-
tion [26].
Conclusions
We determined the draft genome sequence of the highly
virulent, multidrug-resistant A. baumannii NCTC 13423
clinical isolate. The availability of genomic sequences of
clinical A. baumannii isolates from a variety of locations
and sources will benefit comparative genomic studies to
better understand the worrying spread of multidrug re-
sistance in this pathogen.
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Table 4 Number of genes associated with general COG
functional categories
Code Value %age Description
J 177 4.82 Translation, ribosomal structure and biogenesis
A 1 0.03 RNA processing and modification
K 272 7.41 Transcription
L 125 3.40 Replication, recombination and repair
B 0 0.00 Chromatin structure and dynamics
D 32 0.87 Cell cycle control, Cell division, chromosome
partitioning
V 40 1.09 Defense mechanisms
T 97 2.64 Signal transduction mechanisms
M 193 5.26 Cell wall/membrane biogenesis
N 42 1.14 Cell motility
U 88 2.40 Intracellular trafficking and secretion
O 112 3.05 Posttranslational modification, protein
turnover, chaperones
C 202 5.50 Energy production and conversion
G 138 3.76 Carbohydrate transport and metabolism
E 288 7.84 Amino acid transport and metabolism
F 81 2.21 Nucleotide transport and metabolism
H 131 3.57 Coenzyme transport and metabolism
I 182 4.96 Lipid transport and metabolism
P 185 5.04 Inorganic ion transport and metabolism
Q 97 2.64 Secondary metabolites biosynthesis,
transport and catabolism
R 406 11.06 General function prediction only
S 285 7.76 Function unknown
- 498 13.56 Not in COGs
The total is based on the total number of protein coding genes in the genome
Table 3 Genome statistics
Attribute Value % of Total
Genome size (bp) 3,937,944 100
DNA coding (bp) 3,384,768 85.95
DNA G + C (bp) 1,537,664 39.05
DNA scaffolds 196 100
Total genes 3875 100
Protein coding genes 3672 94.76
RNA genes 68 1.75
Pseudo genes 135 3.48
Genes in internal clusters - -
Genes with function prediction 2913 75.17
Genes assigned to COGs 3174 81.91
Genes with Pfam domains 3,002 77.47
Genes with signal peptides 313 8.08
Genes with transmembrane helices 882 22.76
CRISPR repeats 0 -
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